Of all the companies working on the development of potential COVID-19 vaccines and therapeutics, the one highlighted in today’s article – a small Israel-based biotech that specializes in blood plasma-based treatments – is one of the least well-known. However, given that plasma-based therapies have already been shown to be effective in treating severe cases of COVID-19, this company could start getting a lot more attention as its coronavirus therapy moves on to further clinical testing – and that could send its stock soaring. So is this stock a smart buy? CLICK HERE.
